Candriam SCA’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,565,406
| Closed | -$3.86M | – | 737 |
|
|
2023
Q1 | $3.86M | Sell |
1,565,406
-240,000
| -13% | -$592K | 0.03% | 421 |
|
|
2022
Q4 | $14.9M | Sell |
1,805,406
-105,000
| -5% | -$866K | 0.1% | 203 |
|
|
2022
Q3 | $14.7M | Buy |
1,910,406
+1,528,367
| +400% | +$11.8M | 0.1% | 205 |
|
|
2022
Q2 | $1.09M | Hold |
382,039
| – | – | 0.01% | 612 |
|
|
2022
Q1 | $1.91M | Sell |
382,039
-22,597
| -6% | -$113K | 0.01% | 550 |
|
|
2021
Q4 | $7.94M | Hold |
404,636
| – | – | 0.05% | 293 |
|
|
2021
Q3 | $11.9M | Buy |
404,636
+275,038
| +212% | +$8.1M | 0.08% | 243 |
|
|
2021
Q2 | $5.49M | Buy |
+129,598
| New | +$5.49M | 0.04% | 387 |
|